Dr. Wilcox is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2007 - 2011- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2004 - 2007
- Mayo Clinic College of MedicineClass of 2004
Certifications & Licensure
MI State Medical License 2011 - 2027
ID State Medical License 2018 - 2023
MN State Medical License 2005 - 2011- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL Start of enrollment: 2012 Nov 01
- Open-label, Phase II Study of MLN9708 in Patients With Relapsed/Refractory Cutaneous and Peripheral T-cell Lymphomas Start of enrollment: 2014 Sep 01
- Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Start of enrollment: 2016 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsAdding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma.Tycel J Phillips, David Bond, Radihka Takiar, Karson Kump, Malalthi Kandarpa
Blood Advances. 2023-08-22 - 68 citationsPrimary cutaneous lymphomas, version 2.2020. Featured updates to the NCCN guidelinesNeha Mehta-Shah, Steven M. Horwitz, Stephen M. Ansell, Weiyun Z. Ai, Jeffrey A. Barnes
Journal of the National Comprehensive Cancer Network. 2020-05-01 - 16 citationsCutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.Alexandra C Hristov, Trilokraj Tejasvi, Ryan A Wilcox
American Journal of Hematology. 2023-01-01
Abstracts/Posters
- A Phase 2 Study of the Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in Relapsed/Refractory Peripheral T-Cell Lymphoma and C...Ryan A. Wilcox, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malig...Ryan A. Wilcox, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
